Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 21.28
-0.60 (-2.74%)
Apr 29, 2026, 3:06 PM CST
Porton Pharma Solutions Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 128.49 | 96.34 | -287.75 | 266.86 | 2,005 | 523.92 | Upgrade
|
| Depreciation & Amortization | 419.36 | 419.36 | 401.49 | 349.11 | 259.67 | 192.2 | Upgrade
|
| Other Amortization | 53.43 | 53.43 | 44.32 | 30.27 | 6.88 | 4.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.17 | 1.17 | 0.77 | -0.54 | -0.1 | 3.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 22.8 | 22.8 | 92.57 | 58.13 | 18.63 | 16.22 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.52 | -6.52 | 49.24 | 7.76 | 28.18 | 6.79 | Upgrade
|
| Provision & Write-off of Bad Debts | 18.21 | 18.21 | 20.28 | -35.24 | 33.12 | 43.47 | Upgrade
|
| Other Operating Activities | -73.09 | 42.29 | 11.69 | 23.12 | -50.74 | -1.13 | Upgrade
|
| Change in Accounts Receivable | -80.21 | -80.21 | -80.55 | 954.72 | -330.48 | -736.71 | Upgrade
|
| Change in Inventory | -38.21 | -38.21 | -105.9 | 130.04 | -163.58 | -315.56 | Upgrade
|
| Change in Accounts Payable | 191.39 | 191.39 | 289.92 | -1,173 | 732.54 | 756.73 | Upgrade
|
| Operating Cash Flow | 673.79 | 757.01 | 405.53 | 629.06 | 2,564 | 480.17 | Upgrade
|
| Operating Cash Flow Growth | 64.53% | 86.67% | -35.53% | -75.47% | 434.06% | -4.80% | Upgrade
|
| Capital Expenditures | -201.7 | -292.57 | -490.58 | -1,130 | -1,173 | -776.97 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.48 | 3.95 | 2.53 | 2.35 | 1.34 | 6.99 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -233.33 | -171.1 | Upgrade
|
| Investment in Securities | -493.79 | -391.79 | -15 | -20 | -26.5 | 15.51 | Upgrade
|
| Other Investing Activities | 2.17 | 2.56 | 3.1 | 32.76 | -4.65 | 9.4 | Upgrade
|
| Investing Cash Flow | -685.85 | -677.84 | -499.95 | -1,115 | -1,436 | -916.17 | Upgrade
|
| Long-Term Debt Issued | - | 220.41 | 237.98 | 1,119 | 1,345 | 414.64 | Upgrade
|
| Long-Term Debt Repaid | - | -684.23 | -328.64 | -574.14 | -1,266 | -353.43 | Upgrade
|
| Total Debt Repaid | -613.79 | -684.23 | -328.64 | -574.14 | -1,266 | -353.43 | Upgrade
|
| Net Debt Issued (Repaid) | -482.9 | -463.82 | -90.66 | 544.43 | 78.19 | 61.2 | Upgrade
|
| Issuance of Common Stock | 0.22 | - | - | 1.21 | 16.1 | 65.01 | Upgrade
|
| Repurchase of Common Stock | - | - | -9.87 | -19.39 | -100 | - | Upgrade
|
| Common Dividends Paid | -27.17 | -30.11 | -301.5 | -626.57 | -129.08 | -82.76 | Upgrade
|
| Other Financing Activities | 0.63 | - | -11.71 | -28.22 | 395.63 | 306.76 | Upgrade
|
| Financing Cash Flow | -509.22 | -493.92 | -413.74 | -128.54 | 260.84 | 350.22 | Upgrade
|
| Foreign Exchange Rate Adjustments | -21.48 | -11.16 | 4.51 | 55.29 | 49.04 | -9.05 | Upgrade
|
| Net Cash Flow | -542.76 | -425.91 | -503.66 | -558.95 | 1,438 | -94.83 | Upgrade
|
| Free Cash Flow | 472.09 | 464.45 | -85.06 | -500.81 | 1,391 | -296.8 | Upgrade
|
| Free Cash Flow Margin | 13.47% | 13.58% | -2.82% | -13.66% | 19.78% | -9.56% | Upgrade
|
| Free Cash Flow Per Share | 0.83 | 0.87 | -0.16 | -0.92 | 2.56 | -0.55 | Upgrade
|
| Cash Income Tax Paid | - | -1.34 | -67.14 | 30.17 | -137.27 | -73.82 | Upgrade
|
| Levered Free Cash Flow | 819.11 | 237.56 | -158.53 | -1,174 | 905.7 | -513.5 | Upgrade
|
| Unlevered Free Cash Flow | 848.46 | 269.11 | -119.74 | -1,146 | 923.03 | -499.94 | Upgrade
|
| Change in Working Capital | 109.93 | 109.93 | 72.91 | -70.41 | 263.33 | -308.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.